Mobio Announces New Growth Advisory Board to Accelerate Innovation in Mental Health Technology and Precision Psychiatry at Scale

November 28, 2024 (Singapore) – Mobio Interactive announces the addition of three new members to its Growth Advisory Board. The Board, comprised of a diverse group of global industry leaders with extensive experience in digital health, neuroscience, and artificial intelligence, is charged with guiding Mobio's commercial strategy to scaling precision psychiatry with objective, unbiased measures of mental health.

"With the guidance of our new Growth Advisory Board, Mobio is better-positioned to strengthen its role as a pioneering force in digital mental health technology and precision psychiatry," said Arjun Dhaul, President of the Growth Advisory Board at Mobio. "We are thrilled to welcome these leaders to our team. Their collective expertise will be instrumental in driving our mission to enhance access to quality mental health care at a global scale".

New Growth Advisory Board Members

Professor Walter Greenleaf, PhD - Stanford University

• Pioneer in integrating Virtual Reality (VR) into healthcare since 1987
• Decades of experience in digital healthcare research and product development

"The convergence of Artificial Intelligence and Biosensing Technologies is poised to impact healthcare in a very positive way. This technology team-up clears the pathway for developing enhanced methods of clinical care and broader access to effective, personalized care. Mobio Interactive is pioneering the use of mobile app-based assessments and therapeutics to address challenging health conditions such as anxiety, depression, and stress. I am proud to contribute as a member of the Board and believe Mobio's approach to precision psychiatry has immense potential to revolutionize mental health care at scale." – Prof. Walter Greenleaf.

Steve Carnevale - Commissioner, California Mental Health Commission & Brain Capital Entrepreneur

• Founder of the University of Michigan's Center for Entrepreneurship & the UCSF Dyslexia Center
• Governor-appointed Commissioner of the California Mental Health Commission

"Mobio represents one of the best scalable technologies to objectively measure brain health in this new world of precision psychiatry and human performance. The company's innovative approach has the potential to transform mental health care delivery on a global scale, making it more accessible, personalized, and effective." – Steve Carnevale.

Frode Huse Gjendem – Global executive leader and former Chief Data Analytics Officer, Accenture

• Expanded AI business for Healthcare and Pharmaceuticals from $700 million to $1.4 billion
• Developed the Barcelona Center of Excellence as a European reference for consulting and system integration

"I first became familiar with Mobio in 2018 and have followed its journey to becoming a leading provider of precision psychiatry software. As a trained psychotherapist, I believe in leveraging digital technology and AI to enhance access to mental health care and improve treatment quality. I firmly believe that Mobio is essential for achieving better mental health access and treatment outcomes. The company's potential to scale precision psychiatry globally is truly exciting, and I look forward to contributing to Mobio's growth in its client base, projects, and services portfolio, leveraging my experience in the European healthcare and pharmaceutical market." – Frode Huse Gjendem.

Walter, Steve, and Frode join the following Growth Advisory Board Members:

• Dr. Bechara Saab, CEO & Chief Scientist of Mobio Interactive
• Dr. Joseph Mocanu, Founder & Managing Director of Verge HealthTech Fund
• Jon Brilliant, CFO of Mobio Interactive
• Michael Meissner, Former GM of Medtronic and CTO of Sanofi
• Arjun Dhaul, President of the Growth Advisory Board

"The establishment of this Growth Advisory Board reflects Mobio's commitment to fostering impactful growth and innovation in the mental health sector," added Arjun Dhaul. "It marks a pivotal moment in our journey, allowing us to deepen partnerships with health systems and bring much-needed objectivity to mental healthcare management."

Mobio’s CEO & Chief Scientist, Dr Bechara Saab is “extremely grateful that Mobio has such a superstar team to support our growth in the months and years to come. We are always keen to bring more talent into the fold and welcome interested experts and KOLs in this space to reach out.”

About Mobio Interactive

Mobio Interactive is at the forefront of delivering innovative solutions that reshape mental health care. By leveraging cutting-edge technologies in artificial intelligence and big data, Mobio aims to enhance emotional well-being on a global scale. The company's digital tools provide effective, accessible care for conditions such as anxiety, depression, and stress, while pioneering the field of precision psychiatry at scale. For more information about Mobio Interactive or to explore opportunities to join the Growth Advisory Board.

Please contact: mi@mobiointeractive.com.

Media Contact:
Violeta Olmedo
Marketing Intern, Mobio Interactive
violeta@mobiointeractive.com